Voyager Therapeutics Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced the pricing of an …